Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

S.E. Grimm*, W. Witlox, R. Wolff, A. Chalker, M. Hiligsmann, B. Wijnen, C. Ahmadu, S. Ryder, N. Armstrong, S. Duffy, I. Syndikus, J. Kleijnen, M.A. Joore

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Number of pages10
JournalPharmacoeconomics
DOIs
Publication statusE-pub ahead of print - 19 Oct 2021

Cite this